MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Compass Therapeutics, Inc. (CMPX)

Compass Therapeutics, Inc. (CMPX)

|||

Balance Sheets Overview

Current Ratio
1121.59%
Quick Ratio
1121.59%
Cash Ratio
219.82%
Debt to Asset Ratio
12.69%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Operating lease, right-of-use ('...
    • Less accumulated depreciation
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Operating lease obligations, lon...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
35,453
55,168
30,643
46,212
Marketable securities
144,426
139,519
178,263
173,683
Prepaid expenses and other current assets
1,011
1,000
913
1,225
Total current assets
180,890
195,687
209,819
221,120
Total property and equipmentat cost
6,913
6,821
6,739
6,739
Less accumulated depreciation
6,589
6,652
6,637
6,620
Property and equipment, net
324
169
102
119
Operating lease, right-of-use ('rou') asset
8,391
8,746
9,099
9,452
Restricted cash
568
568
568
568
Total assets
190,173
205,170
219,588
231,259
Accounts payable
2,906
906
1,585
3,095
Accrued expenses
11,585
8,000
11,383
8,684
Operating lease obligations, current portion
1,637
1,373
1,000
633
Total current liabilities
16,128
10,279
13,968
12,412
Operating lease obligations, long-term portion
7,996
8,418
8,829
9,234
Total liabilities
24,124
18,697
22,797
21,646
Common stock, 0.0001 par value 300,000 shares authorized 180,088 and 178,324 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
18
18
18
53
Additional paid-in-capital
640,925
636,103
627,665
624,742
Accumulated other comprehensive income (loss)
-251
-159
280
274
Accumulated deficit
-474,643
-449,489
-431,172
-415,456
Total stockholders' equity
166,049
186,473
196,791
209,613
Total liabilities and stockholders' equity
190,173
205,170
219,588
231,259
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$144,426K (84.94%↑ Y/Y)Cash and cashequivalents$35,453K (55.11%↑ Y/Y)Prepaid expenses andother current assets$1,011K (-80.73%↓ Y/Y)Total property andequipmentat cost$6,913K (2.69%↑ Y/Y)Total current assets$180,890K (70.34%↑ Y/Y)Operating lease,right-of-use ('rou') asset$8,391K (-14.41%↓ Y/Y)Restricted cash$568K (0.00%↑ Y/Y)Property and equipment,net$324K (147.33%↑ Y/Y)Less accumulateddepreciation$6,589K (-0.18%↓ Y/Y)Total assets$190,173K (62.96%↑ Y/Y)Total liabilities andstockholders' equity$190,173K (62.96%↑ Y/Y)Total stockholders'equity$166,049K (78.15%↑ Y/Y)Total liabilities$24,124K (2.69%↑ Y/Y)Accumulated deficit-$474,643K (-18.31%↓ Y/Y)Accumulated othercomprehensive income (loss)-$251K (-220.67%↓ Y/Y)Additionalpaid-in-capital$640,925K (29.69%↑ Y/Y)Total currentliabilities$16,128K (16.38%↑ Y/Y)Operating leaseobligations, long-term...$7,996K (-16.99%↓ Y/Y)Common stock, 0.0001par value 300,000...$18K (28.57%↑ Y/Y)Accrued expenses$11,585K (5.39%↑ Y/Y)Accounts payable$2,906K (11.98%↑ Y/Y)Operating leaseobligations, current portion$1,637K (504.06%↑ Y/Y)